← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

M

$ Value

Shares

4,804

Price

Filed

Dec 4

Insider

Name

Lichtenstein Chen

Title

CIK

0002046465

Roles

Director

Transaction Details

Transaction Date

2025-12-02

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,804

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Restricted share units were granted on December 2, 2024 and vested on December 2, 2025.

Filing Info

Accession No.

0001193125-25-308057

Form Type

4

Issuer CIK

0000818686

Lichtenstein Chen's History

Date Ticker Type Value
2025-12-02 TEVA M
2025-12-02 TEVA M $0
2025-06-05 TEVA A $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05